Database
User
| (((4-Methoxyphenoxy)carbonyl)(4-(2-(5-methyl-2-phenyloxazol-4-yl)ethoxy)benzyl)amino)acetic acid | ((4-Methoxy-phenoxycarbonyl)-{4-[2-(5-methyl-2-phenyl-oxazol-4-yl)-ethoxy]-benzyl}-amino)-acetic acid | 2-[(4-methoxyphenoxycarbonyl)({3-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl}methyl)amino]acetic acid |
| 2-[(4-methoxyphenoxycarbonyl)({4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl}methyl)amino]acetic acid | 331741-94-7 | AKOS030255656 |
| BDBM50150998 | BMS 298585 | BMS-298585 |
| BMS298585 | CAS-331741-94-7 | CCRIS 9258 |
| CHEMBL186179 | CTK8E8901 | D05091 |
| DSSTox_CID_31508 | DSSTox_GSID_57719 | DSSTox_RID_97393 |
| DTXSID9057719 | FT-0672555 | Glycine, N-((4-methoxyphenoxy)carbonyl)-N-((4-(2-(5-methyl-2-phenyl-4-oxazolyl)ethoxy)phenyl)methyl)- |
| IRLWJILLXJGJTD-UHFFFAOYSA-N | J-019059 | LS-190838 |
| Muraglitazar | Muraglitazar (USAN/INN) | Muraglitazar [USAN:INN] |
| N-((4-methoxyphenoxy)carbonyl)-N-((4-(2-(5-methyl-2-phenyl-4-oxazolyl)ethoxy)phenyl)methyl)glycine | N-[[4-methoxyphenoxy)carbonyl]-N-[(4-[2-(5-methyl-2-phenyl-4-oxazolyl)-ethoxy]phenyl]methyl]glycine | NCGC00262954-01 |
| Pargluva | Q6937233 | RT-013967 |
| SCHEMBL676469 | Tox21_113946 | UNII-W1MKM70WQI |
| W1MKM70WQI | ZINC000049650290 | ZINC49650290 |
| [C14]-2-((4-methoxyphenoxy)carbonyl)acetic acid |
| DrugBank Name | Muraglitazar |
| DrugBank | DB06510 |
| CAS Number | 331741-94-7 |
| PubChem Compound | 206044 |
| KEGG Drug | D05091 |
| PharmGKB | PA162356187 |
| ChemSpider | 178524 |
| BindingDB | 50150998.0 |
| Wikipedia | Muraglitazar |